2,4-dichlorobenzyl alcohol + allantoin + cetrimide: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
2,4-dichlorobenzyl alcohol + allantoin + cetrimide: clinical details
Prescribing considerations
- Confirm that the injury is minor and superficial; this preparation does not replace debridement, closure, systemic treatment or burn assessment when indicated.
- Reassess spreading redness, increasing pain, heat, swelling, pus, fever or failure to improve.
- For burns, prioritise immediate cooling and severity assessment before topical treatment.
Contraindications and cautions
- Hypersensitivity to 2,4-dichlorobenzyl alcohol, allantoin, cetrimide or an excipient.
- Do not use as sole management for large, deep, electrical or chemical burns.
Monitoring
- No routine laboratory monitoring is required.
- Monitor local tolerability and the wound for deterioration or infection.
Clinical pharmacology
Cetrimide is a quaternary ammonium antiseptic that damages microbial membranes. The combination adds the local antiseptic activity of 2,4-dichlorobenzyl alcohol and allantoin as a skin-conditioning and repair-supporting component.
Formulation and product differences
- The product is a topical cream containing all three active ingredients.
- The cream base includes cetostearyl alcohol, paraffin components, dimeticone and perfume; consider excipient sensitivity in people with previous contact reactions.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.